Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Matsubara

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Scientific Reports|December 15, 2022
Nuclear and magnetic spin structure of the antiferromagnetic triangular lattice compound LiCrTe<sub>2</sub> investigated by [Formula: see text]SR, neutron and X-ray diffractionE Nocerino, C Witteveen, S Kobayashi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trialA O Siefker-Radtke, N Matsubara, S H Park, et al.
Gut|July 13, 2004
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectumT Kambara, L A Simms, V L J Whitehall, et al.
Breast Cancer (Tokyo, Japan)|March 13, 2026
Expression of HER2, HER3, and TROP2 in primary tumors and brain metastases of breast cancerS Kusuhara, T Kogawa, M Shimokawa, et al.
Cancer Research|June 15, 1997
Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumorsR F Souza, J Yin, K N Smolinski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2025
Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resistant prostate cancer: the randomized, double-blind, phase III KEYNOTE-641 studyJ N Graff, M Burotto, P C Fong, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 19, 2008
The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibilityY Niki, H Hanaki, M Yagisawa, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 26, 2009
Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens' antibacterial susceptibilityY Niki, H Hanaki, T Matsumoto, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Scientific Reports|December 15, 2022
Nuclear and magnetic spin structure of the antiferromagnetic triangular lattice compound LiCrTe<sub>2</sub> investigated by [Formula: see text]SR, neutron and X-ray diffractionE Nocerino, C Witteveen, S Kobayashi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trialA O Siefker-Radtke, N Matsubara, S H Park, et al.
Gut|July 13, 2004
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectumT Kambara, L A Simms, V L J Whitehall, et al.
Breast Cancer (Tokyo, Japan)|March 13, 2026
Expression of HER2, HER3, and TROP2 in primary tumors and brain metastases of breast cancerS Kusuhara, T Kogawa, M Shimokawa, et al.
Cancer Research|June 15, 1997
Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumorsR F Souza, J Yin, K N Smolinski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2025
Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resistant prostate cancer: the randomized, double-blind, phase III KEYNOTE-641 studyJ N Graff, M Burotto, P C Fong, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|August 19, 2008
The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibilityY Niki, H Hanaki, M Yagisawa, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|June 26, 2009
Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens' antibacterial susceptibilityY Niki, H Hanaki, T Matsumoto, et al.
Pageof 14